# Fucoidan Assisted Eradication of Helicobacter Pylori

> **NCT05461508** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Helicobacter Pylori Infection
- Intestinal Bacteria Flora Disturbance

## Interventions

- **BIOLOGICAL:** Amoxicillin combined with vonoprazan and fucoidan
- **OTHER:** Amoxicillin combined with vonoprazan

## Key facts

- **NCT ID:** NCT05461508
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05461508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05461508, "Fucoidan Assisted Eradication of Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05461508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*